Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program

References

• Steptoe P C, Edwards R G. Birth after the reimplantation of a human embryo. Lancet 1978; ii: 366
   Google Scholar
• Meldrum D R, Wisot A, Hamilton F, et al. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989; 51: 45–9
   Google Scholar
• Kubik C J, Guzick D S, Berga S L, et al. Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilization and gamete intra-Fallopian transfer. Fertil Steril 1990; 54: 836–41
   Google Scholar
• Hughes E G, Federkow D M, Daya S, et al. The routine use of gonadotropin-releasing hormone agonist prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992; 58: 888–96
   PubMed Web of Science ®Google Scholar
• Rizk B, Smith J. Ovarian hyperstimulation syndrome after superovulation for IVF and related procedures. Hum Reprod 1992; 7: 320–7
   PubMedGoogle Scholar
• Grochowski D, Sola E, Kulikowski M, et al. Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis. J Assist Reprod Genet 1995; 12: 6–8
   Google Scholar
• De Mouzon J, Lancaster P. World Collaborative Report. 1995, XVth World Congress on Fertility and Sterility, Montpellier
   Google Scholar
• Whittemore A S, Harris R, Itnyre J. Characteristics leading to ovarian cancer risk. Collaborative analysis of 12 U.S. case-controlled studies. Am J Epidemiol 1992; 136: 1184–203
   PubMed Web of Science ®Google Scholar
• Rossing M A, Daling J R, Weiss N S, et al. Ovarian tumours in a cohort of infertile women. N Engl J Med. 1994; 331: 771–6
   PubMed Web of Science ®Google Scholar
• Tarlatzis B, Grimbizis G, Bontis J, et al. Ovulation stimulation and ovarian tumours: a critical reappraisal. Hum Reprod Update 1995; 1: 284–301
   Google Scholar
• Edwards R G, Lobo R A, Bouchard P. Time to revolutionise ovarian stimulation. Hum Reprod 1996; 11: 917–9
   PubMed Web of Science ®Google Scholar
• Ferrier A, Rasweiler J J, Bedford J M, et al. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer. Fertil Steril 1990; 54: 90–5
   Google Scholar
• Antoine J M, Salat-Baroux J, Alvarez S, et al. Ovarian stimulation using human menopausal gonadotropins with or without LHRH analogues in a long protocol for in vitro fertilization: a prospective randomized comparison. Hum Reprod 1990; 5: 565–9
   PubMed Web of Science ®Google Scholar
• Ron-El R, Herman A, Golan A, et al. Gonadotropins and combined gonadotropin–releasing hormone agonist–gonadotropins protocols in a randomized prospective study. Fertil Steril 1991; 55: 574–8
   Google Scholar
• Maroulis G B, Emery M, Verkauf B S, et al. Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog–human menotropin stimulation protocols for in vitro fertilization. Fertil Steril 1991; 55: 1157–64
   PubMedGoogle Scholar
• Kingsland C, Tan S L, Bickerton N, et al. The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization. Is there any medical advantage? A prospective randomized study. Fertil Steril 1992; 57: 804–7
   Google Scholar
• Tummon I S, Daniel SAJ, Kaplan B R, et al. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization. Fertil Steril 1992; 58: 563–8
   PubMed Web of Science ®Google Scholar
• Harrison R F, Kondaveeti U, Barry-Kinsella C, et al. Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?. Fertil Steril 1994; 62: 568–73
   PubMedGoogle Scholar
• Dhont M, Onghena A, Coetsier T, et al. Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction. Hum Reprod 1995; 10: 791–6
   PubMedGoogle Scholar
• Palermo G, Joris H, Devroey P, et al. Pregnancy after intracytoplasmic injection of a single spermatozoon into an oocyte. Lancet 1992; ii: 17–8
   Google Scholar
• Porter R N, Smith W, Craft I L, et al. Induction of ovulation for in vitro fertilization using buserelin and gonadotropins. Lancet 1984; ii: 1284–5
   Google Scholar
• Smitz J, Ron-El R, Tarlatzis B C. The use of gonadotrophin releasing hormone agonists for in-vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod 1992; 7(Suppl 1)49–49
   Google Scholar
• Grochowski D, Wołczyński S, Kulikowski M, et al. Prevention of high-order multiple gestations in an in vitro fertilization program. Gynecol Endocrinol 1997; 11: 327–30
   Web of Science ®Google Scholar
• Edwards R G, Lobo R A, Bouchard P. Why delay the obvious need for milder forms of ovarian stimulation?. Hum Reprod 1997; 12: 399–401
   PubMedGoogle Scholar
• Testart J, Belaisch-Allart J, Forman R, et al. Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability. Hum Reprod 1989; 4: 192–7
   PubMed Web of Science ®Google Scholar
• Testart J, Forman R, Belaisch-Allart J, et al. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone. Hum Reprod 1989; 4: 198–201
   Google Scholar
• Van der Elst J, Van den Abbeel E, Camus M, et al. Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate–human menopausal gonadotrophin (HMG) or clomiphene citrate–HMG. Hum Reprod 1996; 11: 2097–106
   Google Scholar
• Lornage J, Boulieu D, Methieu C. Transfers of frozen–thawed human embryos in cycles stimulated by HMG. Hum Reprod 1990; 5: 60–5
   Google Scholar
• MacDougall M J, Tan S L, Jacobs H S. In vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992; 7: 597–600
   PubMedGoogle Scholar